Skip to content

Journal of Psychiatry and Neuroscience

ISSN 1180-4882

5 papers in the library · 62 citations · publishing 2003-2024

Papers

Sort Most recent Most cited

CCNP Innovations in Neuropsychopharmacology Award

Journal of Psychiatry and Neuroscience September 19, 2024 Gabriella Gobbi 7 citations

For 3000 years, psychedelics have been used in religious contexts to enhance spiritual thinking, well-being, and a sense of community. In the last few years, a renaissance in the use of psychedelic drugs for mental disorders has occurred in Western society; consequently, a pressing scientific need to elucidate the intricate mechanisms underlying their actions has arisen. Psychedelics mainly...

Serotonergic psychedelic treatment for obesity and eating disorders: potential expectations and caveats for emerging studies

Journal of Psychiatry and Neuroscience June 1, 2022 Stephanie L. Borgland, Drew M. Neyens 14 citations

There has been a substantial growth in private clinics and registered clinical trials employing serotonergic psychedelics for various psychiatric illnesses, including substance use disorder[1][1],[2][2] and major depressive disorder.[3][3]–[6][4] Classical psychedelics include lysergic acid

Impaired cognitive performance under psychosocial stress in cannabis-dependent men is associated with attenuated precuneus activity

Journal of Psychiatry and Neuroscience February 26, 2020 Weihua Zhao, Kaeli Zimmermann, Xinqi Zhou et al. 14 citations

Background: Deficient regulation of stress plays an important role in the escalation of substance use, addiction and relapse. Accumulating evidence suggests dysregulations in cognitive and reward-related processes and the underlying neural circuitry in cannabis dependence. However, despite the important regulatory role of the endocannabinoid system in the stress response, associations between...

Biologic effects of mindfulness meditation: growing insights into neurobiologic aspects of the prevention of depression

Journal of Psychiatry and Neuroscience March 1, 2011 Simon N. Young 23 citations

A recent paper in the Archives of General Psychiatry confirms that mindfulness-based cognitive therapy (MBCT) “offers protection against relapse/recurrence on a par with that of maintenance antidepressant pharmacotherapy.”[1][1] It is a tribute to the accumulated wisdom of humankind that a

The Psychopharmacology of Herbal Medicine: Plant Drugs That Alter Mind, Brain and Behavior

Journal of Psychiatry and Neuroscience July 1, 2003 Ronald T. Coutts 4 citations

This paperback publication has 428 pages of text, an additional 131 pages of references and an 18-page subject index. The text is organized in 10 chapters, each liberally endowed with relevant figures and tables. The first 3 chapters (72 pages) are very useful because they contain numerous definitions and introduce the reader to neuroscientific and pharmacological topics that appear throughout...